Levacor™ Ventricular Assist Device (VAD) Bridge to Transplant Study

Refractory Heart Failure Clinical Trial

Official title:
Evaluation of the Levacor™ Ventricular Assist Device as a Bridge to Cardiac Transplantation

Status Terminated

Clinical Trial Summary

The Levacor™ Ventricular Assist Device (VAD) has been designed for mechanical circulatory support in heart failure patients. The purpose of this clinical study is to determine its safety and efficacy as a bridge to transplant (BTT) in cardiac transplant candidates with presumed non-reversible left ventricular failure.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Refractory Heart Failure

Clinical Trial Details

NCT number	NCT01001793
Study type	Interventional
Source	World Heart Corporation
Contact
Status	Terminated
Phase	N/A
Start date	August 2009
Completion date	July 2011

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT05876000` - Corheart 6 VAS Study	N/A
	Completed	`NCT01758627` - The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease	N/A